States he had a similar episode and was hospitalized for pancreatitis [**2164-11-16**] where he was admitted with 1 day h/o abdominal pain, initial elevation of lipase and amylase consistent with gallstone pancreatitis.
Pancreatitis [**11-9**] initially admitted to Dr. [**Last Name (STitle) 1120**], followed by Dr. [**Last Name (STitle) **].
Physical Exam: On Admission: Gen: resting comfortably HEENT: no jaundice, PERRL, trachea midline Abd: soft, mildly distended, no rebound or guarding, tenderness over epigastrium, positive bowel sounds CVS: tachycardic, positive S1 and S2, no S3 or S4 Chest: clear to auscultation bilaterally Ext: no edema, positive distal pulses   Pertinent Results: On Admission:  [**2165-3-2**] 05:18PM   AMYLASE-530* [**2165-3-2**] 05:18PM   LIPASE-1654* [**2165-3-2**] 08:20AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-0.2 PH-5.0 LEUK-NEG [**2165-3-2**] 08:18AM   LACTATE-3.5* [**2165-3-2**] 04:15AM   GLUCOSE-173* UREA N-16 CREAT-0.8 SODIUM-139 POTASSIUM-3.7 CHLORIDE-97 TOTAL CO2-26 ANION GAP-20 [**2165-3-2**] 04:15AM   ALT(SGPT)-48* AST(SGOT)-43* ALK PHOS-119 TOT BILI-0.2 DIR BILI-0.1 INDIR BIL-0.1 [**2165-3-2**] 04:15AM   LIPASE-4605* [**2165-3-2**] 04:15AM   ALBUMIN-4.9 [**2165-3-2**] 04:15AM   WBC-20.5*# RBC-4.93# HGB-15.9# HCT-45.3# MCV-92# MCH-32.3* MCHC-35.1* RDW-12.9 [**2165-3-2**] 04:15AM   NEUTS-83.5* LYMPHS-13.5* MONOS-2.3 EOS-0.2 BASOS-0.4 [**2165-3-2**] 04:15AM   PLT COUNT-413# .
Brief Hospital Course: The patient was admitted to the General Surgical Service in the TSICU on [**2165-3-2**] for evaluation and treatment of epigastric pain and elevated pancreatic enzymes, initially consistent with gallstone pancreatitis.
He was made NPO, given IV fluid rescusitation, a foley catheter was placed, and Dilaudid IV PRN for pain with good effect.
When tolerating oral intake, the patient was transitioned to oral pain medications with continued good pain control.
GI/GU/FEN: Upon admission, the patient was made NPO and received aggressive IV fluid rescusitation.
Foley was discontinued on [**3-5**]; he was subsequently able to void without peoblem.
Endocrine: The patient's blood sugar was monitored throughout his stay; sliding scale insulin dosing was administered when required.
He did not require exogenous insulin at discharge.
Prophylaxis: The patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible.
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Omeprazole 40 mg Capsule, Delayed Release(E.C.)
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation.
Percocet 5-325 mg Tablet Sig: 1-2 Tablets PO every 4-6 hours as needed for pain.
Disp:*30 Tablet(s)* Refills:*0*  Discharge Disposition: Home  Discharge Diagnosis: Recurrent pancreatitis   Discharge Condition: Mental Status:Clear and coherent Level of Consciousness:Alert and interactive Activity Status:Ambulatory - Independent   Discharge Instructions: Please resume all regular home medications , unless specifically advised not to take a particular medication.
Also, please take any new medications as prescribed.
Avoid driving or operating heavy machinery while taking pain medications.
If you do not have a PCP and would like to establish with one here at [**Hospital1 18**], please call ([**Telephone/Fax (1) 1921**].
